We are monitoring the impact of COVID-19 on Lung Cancer Diagnostics Market Get in touch with us for detailed analysis Know More
Pulished Date January, 2021
ID: 10818
Share on
Share on

Global Lung Cancer Diagnostics Market Size, Share, Trends and Growth Analysis Report – Segmented By Type, Test and Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa) – Industry Forecast (2020 to 2025)

Pulished: January, 2021
ID: 10818
Pages: 190

Lung Cancer Diagnostics Market Size (2020 to 2025)

The global lung cancer diagnostics market size is estimated to be worth USD 4.01 billion by 2025.

Lung cancer is a leading cause of death among many people across the world. Around 154,000 American deaths are due to lung cancer every year, particularly in the US. Lung cancer is high compared with deaths due to breast and prostate cancers. World Health Organization (WHO) has established the safe levels of air pollution where thousands of cities have air pollution significantly higher than the levels. Billions of people are exposed to dangerous air, which is associated with an increase in the number of lung cancer cases. According to a recent survey, around 8.5 million deaths are occurring due to exposure to air pollution. World Health Organization (WHO) stated that approximately 80% of the total population are addicted to smoking worldwide, which is a significant factor in the occurrences of lung cancer diseases.

MARKET DRIVERS:

The rise in the prevalence of smoking and alcohol consumption is a significant factor in lung disorders. The lung cancer diagnostics market's growth is influenced by the surge of cancer dominancy and the rise of high demand for early diagnosis. Increase of awareness levels among the population and the rise of public and private funds for R&D activities to get better tumor diagnostic tools are leveraging the market's demand. Increasing investments in the development of healthcare services are also enhancing the need of the market. The rise of encouragement to build awareness among the public is propelling the growth of the lung cancer diagnostics market. Prior to the early diagnosis and increasing severity of the disease are ascribed to bolster the growth rate of the market. The rising number of deaths due to lung cancer and the growing prevalence of the development of new diagnostics procedures are elevating the growth rate of the market.

MARKET RESTRAINTS:

The treatment procedures are a bit expensive, where ordinary people cannot afford them is slowly degrading the market's growth rate. Fewer reimbursement policies in the undeveloped countries and a lack of skilled professionals inhibit the demand of the market.  

Impact of COVID-19 on the global lung cancer diagnostics market:

COVID-19 has disrupted every sector except for healthcare. During the first half of 2020, the diagnostic tool market has been slightly decreased due to lockdown restrictions and a ban on international flights. As COVID-19 shows severe illness on the respiratory system, the patients with lung cancer have to take proper medications to avoid death risk. With the proper precautions like maintaining social distancing and wearing masks, the diagnostic centers have resumed the activities and giving accurate services for the customers. The lung cancer diagnostic market is in full swing during the pandemic and is expected to have the highest shares in the coming years.

REPORT COVERAGE

REPORT METRIC

DETAILS

Market Size Available

2019 to 2025

Base Year

2019

Forecast Period

2020 to 2025

Segments Covered

By Type, Test and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

 

This market research report on the global lung cancer diagnostics market has been segmented based on the technology, application, and region.

Lung cancer diagnostics market – By Type:

  • Small-cell
  • Non-small cell

Based on the type, the Non-small cell type is leading with the dominant shares of the market. Rising research and development activities and an increasing geriatric population are promoting the market's growth rate. Along with this, the rising demand to lower the risk due to lung cancer by diagnosing it at an early stage is merely to leverage the growth rate of the market.

Lung cancer diagnostics Market – By Test:

  • Imaging test
  • Sputum cytology
  • Biopsy
  • Molecular testing

Based on the test segment, the imaging test segment is holding the market's dominant shares due to increasing incidences of chronic diseases and growing awareness over the availability of different treatment procedures. Adoption of the latest technologies in imaging systems is leveraging the demand of the market. Molecular testing is holding second place in ruling the shares of the market. Ongoing research in developing effective diagnostic procedures to find the abnormalities at an early stage is prompting the growth rate of this segment to the extent.

Lung cancer diagnostics market – By Region:

  • North America
    • The United States
    • Canada
    • Rest of North America
  • Europe
    • United Kingdom       
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Japan
    • ANZ
    • South Korea
    • Rest of APAC
  • Latin America
    • Mexico
    • Brazil
    • Argentina
    • Chile
    • Rest of Latin America
  • Middle East
  • Africa

Geographically, the North America region is ruling with the highest shares of the market and is to continue the same flow in the foreseen years. Factors like rising initiatives steps by government and the adoption of advanced technology are majorly propelling the market demand in this region. Additionally, the adoption of sedentary lifestyles and food habits changes are likely to fuel the market's direction. The US is having the dominant shares of the market. An increasing number of patients diagnosed with lung cancer is leveling up the demand of the market. In the U.S, around 215,951 million people were diagnosed with lung cancer disease, and 155,526 people lost lives due to this disease. Europe is next to North America, leading the highest shares of the market by constant economic growth and rising disposable income.

Europe is projected to grow at a rate of 7.8% during the forecast period. Also, government investments in the development of new products are ascribed to boost up the demand for the lung cancer diagnostics market. Rising healthcare expenditure and the growing need to diagnose the diseases at the initial stages are likely to propel the market demand.

The Asia Pacific is expected to grow at a higher rate in the coming years with the increasing geriatric population and rise in the demand to promote quality treatment procedures. China is the primary country to contribute the highest shares for the market. China is growing at a CAGR of 11.4% from 2020 to 2025. Increasing incidences of chronic illness and rising support from the public and private organizations are anticipated to set growth opportunities for the market. India is deemed to have high growth opportunities in the coming years with the increasing population and growing funds from the government in the healthcare sector. 

KEY MARKET PARTICIPANTS:

Roche Diagnostics, bioMérieux, Qiagen N.V., Thermo Fisher Scientific, Agilent Technologies, and Sanofi S.A. are some of the noteworthy companies dominating the space of lung cancer diagnostics market.

MAJOR HAPPENINGS IN THIS MARKET IN THE RECENT PAST:

  • In 2020, COVID 19 screening test named ''Droplet Digital PCR' had been launched by Biodesix Inc. This diagnostic tool has received approval from the food and drug administration. The launch of this product has increased the product portfolio of the company.
  • In February 2020, Cepheid announced that it signed an agreement with Sherlock Biosciences to introduce effective and innovative diagnostic test kits for the oncology department. 
  1. Introduction
    1. Market Definition
    2. Study Deliverables
    3. Base Currency, Base Year and Forecast Periods
    4. General Study Assumptions
  2. Research Methodology
    1. Introduction
    2. Research Phases
        1. Secondary Research
        2. Primary Research
        3. Econometric Modelling
        4. Expert Validation
    3. Analysis Design
    4. Study Timeline
  3. Overview
    1. Executive Summary
    2. Key Inferences
    3. New Developments
  4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
    1. Market Drivers
    2. Market Restraints
    3. Key Challenges
    4. Current Opportunities in the Market
  5. Market Segmentation
    1. By Type
      1. Small-cell
      2. Non-small cell
      3. Y-o-Y Growth Analysis, By Type
      4. Market Attractiveness Analysis, By Type
      5. Market Share Analysis, By Type
    2. By Test
      1. Imaging test
      2. Sputum cytology
      3. Biopsy
      4. Molecular testing
      5. Y-o-Y Growth Analysis, By Test
      6. Market Attractiveness Analysis, By Test
      7. Market Share Analysis, By Test
  6. Geographical Analysis
    1. Introduction    
      1. Regional Trends       
      2. Impact Analysis        
      3. Y-o-Y Growth Analysis            
        1. By Geographical Area
        2. By Type
        3. By End User
      4. Market Attractiveness Analysis          
        1. By Geographical Area
        2. By Type
        3. By End User
      5.          Market Share Analysis   
        1. By Geographical Area
        2. By Type
        3. By End User
    2. Asia-Pacific
      1. Introduction
      2. India
      3. China
      4. Japan
      5. South Korea
      6. Australia
      7. Rest of Asia-Pacific
  7. Strategic Analysis
    1. PESTLE analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
      5. Legal
      6. Environmental
    2. Porter’s Five analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Consumers
      3. Threat of New Entrants
      4. Threat of Substitute Products and Services
      5. Competitive Rivalry within the Industry
  8. Market Leaders' Analysis
    1. Roche Diagnostics
      1. Overview
      2. Product Analysis
      3. Strategic Evaluation and Operations
      4. Financial analysis
      5. Legal issues
      6. Recent Developments
      7. SWOT analysis
      8. Analyst View
    2. bioMérieux
    3. Qiagen N.V.
    4. Thermo Fisher Scientific
    5. Agilent Technologies
    6. Sanofi S.A.
  9. Competitive Landscape
    1. Merger and Acquisition Analysis
    2. Agreements, Collaborations and Joint Ventures
    3. New Product Launches
  10. Market Outlook and Investment Opportunities
  11. Appendix
    1. List of Tables
    2. List of Figures  
  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.
  • The segment-level analysis in terms of test and type along with market size forecasts and estimations to detect key areas of industry growth in detail.
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics.
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis.
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development.
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment.
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies.
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions.
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market.
  1. Global Lung Cancer Diagnostics Market, By Region, From 2020 to 2025 (USD Million)
  2. Global Lung Cancer Diagnostics Market, By Type, From 2020 to 2025 (USD Million)
  3. Global Small Cell Market, By Region, From 2020 to 2025 (USD Million)
  4. Global Non-small cell Market, By Region, From 2020 to 2025 (USD Million)
  5. Global Lung Cancer Diagnostics Market, By Test, From 2020 to 2025 (USD Million)
  6. Global Imaging test Market, By Region, From 2020 to 2025 (USD Million)
  7. Global Sputum Cytology Market, By Region, From 2020 to 2025 (USD Million)
  8. Global Biospy Market, By Region, From 2020 to 2025 (USD Million)
  9. Global Molecular Testing Market, By Region, From 2020 to 2025 (USD Million)
  10. North America Lung Cancer Diagnostics Market, By Type, From 2020 to 2025 (USD Million)
  11. North America Small Cell Market, By Region, From 2020 to 2025 (USD Million)
  12. North America Non-small cell Market, By Region, From 2020 to 2025 (USD Million)
  13. North America Lung Cancer Diagnostics Market, By Test, From 2020 to 2025 (USD Million)
  14. North America Imaging test Market, By Region, From 2020 to 2025 (USD Million)
  15. North America Sputum Cytology Market, By Region, From 2020 to 2025 (USD Million)
  16. North America Biospy Market, By Region, From 2020 to 2025 (USD Million)
  17. North America Molecular Testing Market, By Region, From 2020 to 2025 (USD Million)
  18. United States Lung Cancer Diagnostics Market, By Type, From 2020 to 2025 (USD Million)
  19. United States Lung Cancer Diagnostics Market, By Test, From 2020 to 2025 (USD Million)
  20. Canada Lung Cancer Diagnostics Market, By Type, From 2020 to 2025 (USD Million)
  21. Canada Lung Cancer Diagnostics Market, By Test, From 2020 to 2025 (USD Million)
  22. Europe Lung Cancer Diagnostics Market, By Type, From 2020 to 2025 (USD Million)
  23. Europe Small Cell Market, By Region, From 2020 to 2025 (USD Million)
  24. Europe Non-small cell Market, By Region, From 2020 to 2025 (USD Million)
  25. Europe Lung Cancer Diagnostics Market, By Test, From 2020 to 2025 (USD Million)
  26. Europe Imaging test Market, By Region, From 2020 to 2025 (USD Million)
  27. Europe Sputum Cytology Market, By Region, From 2020 to 2025 (USD Million)
  28. Europe Biospy Market, By Region, From 2020 to 2025 (USD Million)
  29. Europe Molecular Testing Market, By Region, From 2020 to 2025 (USD Million)
  30. U.K. Lung Cancer Diagnostics Market, By Type, From 2020 to 2025 (USD Million)
  31. U.K. Lung Cancer Diagnostics Market, By Test, From 2020 to 2025 (USD Million)
  32. Germany Lung Cancer Diagnostics Market, By Type, From 2020 to 2025 (USD Million)
  33. Germany Lung Cancer Diagnostics Market, By Test, From 2020 to 2025 (USD Million)
  34. France Lung Cancer Diagnostics Market, By Type, From 2020 to 2025 (USD Million)
  35. France Lung Cancer Diagnostics Market, By Test, From 2020 to 2025 (USD Million)
  36. Italy Lung Cancer Diagnostics Market, By Type, From 2020 to 2025 (USD Million)
  37. Italy Lung Cancer Diagnostics Market, By Test, From 2020 to 2025 (USD Million)
  38. Spain Lung Cancer Diagnostics Market, By Type, From 2020 to 2025 (USD Million)
  39. Spain Lung Cancer Diagnostics Market, By Test, From 2020 to 2025 (USD Million)
  40. Asia Pacific Lung Cancer Diagnostics Market, By Type, From 2020 to 2025 (USD Million)
  41. Asia Pacific Small Cell Market, By Region, From 2020 to 2025 (USD Million)
  42. Asia Pacific Non-small cell Market, By Region, From 2020 to 2025 (USD Million)
  43. Asia Pacific Lung Cancer Diagnostics Market, By Test, From 2020 to 2025 (USD Million)
  44. Asia Pacific Imaging test Market, By Region, From 2020 to 2025 (USD Million)
  45. Asia Pacific Sputum Cytology Market, By Region, From 2020 to 2025 (USD Million)
  46. Asia Pacific Biospy Market, By Region, From 2020 to 2025 (USD Million)
  47. Asia Pacific Molecular Testing Market, By Region, From 2020 to 2025 (USD Million)
  48. Japan Lung Cancer Diagnostics Market, By Type, From 2020 to 2025 (USD Million)
  49. Japan Lung Cancer Diagnostics Market, By Test, From 2020 to 2025 (USD Million)
  50. China Lung Cancer Diagnostics Market, By Type, From 2020 to 2025 (USD Million)
  51. China Lung Cancer Diagnostics Market, By Test, From 2020 to 2025 (USD Million)
  52. India Lung Cancer Diagnostics Market, By Type, From 2020 to 2025 (USD Million)
  53. India Lung Cancer Diagnostics Market, By Test, From 2020 to 2025 (USD Million)
  54. Australia Lung Cancer Diagnostics Market, By Type, From 2020 to 2025 (USD Million)
  55. Australia Lung Cancer Diagnostics Market, By Test, From 2020 to 2025 (USD Million)
  56. South Korea Lung Cancer Diagnostics Market, By Type, From 2020 to 2025 (USD Million)
  57. South Korea Lung Cancer Diagnostics Market, By Test, From 2020 to 2025 (USD Million)
  58. Latin America Lung Cancer Diagnostics Market, By Type, From 2020 to 2025 (USD Million)
  59. Latin America Small Cell Market, By Region, From 2020 to 2025 (USD Million)
  60. Latin America Non-small cell Market, By Region, From 2020 to 2025 (USD Million)
  61. Latin America Lung Cancer Diagnostics Market, By Test, From 2020 to 2025 (USD Million)
  62. Latin America Imaging test Market, By Region, From 2020 to 2025 (USD Million)
  63. Latin America Sputum Cytology Market, By Region, From 2020 to 2025 (USD Million)
  64. Latin America Biospy Market, By Region, From 2020 to 2025 (USD Million)
  65. Latin America Molecular Testing Market, By Region, From 2020 to 2025 (USD Million)
  66. Brazil Lung Cancer Diagnostics Market, By Type, From 2020 to 2025 (USD Million)
  67. Brazil Lung Cancer Diagnostics Market, By Test, From 2020 to 2025 (USD Million)
  68. Argentina Lung Cancer Diagnostics Market, By Type, From 2020 to 2025 (USD Million)
  69. Argentina Lung Cancer Diagnostics Market, By Test, From 2020 to 2025 (USD Million)
  70. Mexico Lung Cancer Diagnostics Market, By Type, From 2020 to 2025 (USD Million)
  71. Mexico Lung Cancer Diagnostics Market, By Test, From 2020 to 2025 (USD Million)
  72. Rest of Latin America Lung Cancer Diagnostics Market, By Type, From 2020 to 2025 (USD Million)
  73. Rest of Latin America Lung Cancer Diagnostics Market, By Test, From 2020 to 2025 (USD Million)
  74. Middle East and Africa Lung Cancer Diagnostics Market, By Type, From 2020 to 2025 (USD Million)
  75. Middle East and Africa Small Cell Market, By Region, From 2020 to 2025 (USD Million)
  76. Middle East and Africa Non-small cell Market, By Region, From 2020 to 2025 (USD Million)
  77. Middle East and Africa Lung Cancer Diagnostics Market, By Test, From 2020 to 2025 (USD Million)
  78. Middle East and Africa Imaging test Market, By Region, From 2020 to 2025 (USD Million)
  79. Middle East and Africa Sputum Cytology Market, By Region, From 2020 to 2025 (USD Million)
  80. Middle East and Africa Biospy Market, By Region, From 2020 to 2025 (USD Million)
  81. Middle East and Africa Molecular Testing Market, By Region, From 2020 to 2025 (USD Million)
  82. Middle East Lung Cancer Diagnostics Market, By Type, From 2020 to 2025 (USD Million)
  83. Middle East Lung Cancer Diagnostics Market, By Test, From 2020 to 2025 (USD Million)
  84. Africa Lung Cancer Diagnostics Market, By Type, From 2020 to 2025 (USD Million)
  85. Africa Lung Cancer Diagnostics Market, By Test, From 2020 to 2025 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4250

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample